United-Guardian, Inc. (UG) Dividend History

United-Guardian, Inc. (UG) is a diversified manufacturer of specialty personal care, health, and industrial products. Founded in 1946, the company develops and markets a range of proprietary formulations, including personal care products, pharmaceuticals, and industrial chemicals, serving clients worldwide. Known for its innovation and quality, United-Guardian focuses on niche markets with unique product offerings.

230 Marcus Blvd, Hauppauge, NY, 11788
Phone: 631-273-0900
Website: https://www.u-g.com
Dividend Yield: 7.05%

Dividend History

Pay Date Amount Ex Dividend Date Record Date
August 01, 2025 $0.25 07/25/2025 07/25/2025
February 18, 2025 $0.35 02/10/2025 02/10/2025
July 31, 2024 $0.35 07/23/2024 07/23/2024
February 20, 2024 $0.25 02/09/2024 02/12/2024
August 02, 2023 $0.10 07/25/2023 07/26/2023
Show more

Dividends Summary

  • United-Guardian, Inc. has issued 46 dividend payments over the past 21 years
  • The most recent dividend was paid 37 days ago, on August 1, 2025
  • The first recorded dividend was paid on January 5, 2004
  • The highest dividend payout was $0.65 per share
  • The average dividend over this 21 year span is $0.37 per share
  • United-Guardian, Inc. has increased its dividend payments by 66.67% since 2004

Company News

  • United-Guardian (UG) Q2 Sales Drop 16%

    United-Guardian reported a 16.3% revenue decline in Q2 2025, primarily due to weak cosmetic ingredient sales from distributor inventory issues. Medical lubricants and pharmaceutical products showed growth, with management hopeful for cosmetic sales recovery in the second half of the year.

    The Motley Fool
  • United-Guardian Reports 2024 Financial Results

    United-Guardian, Inc. reported a 12% increase in net sales and a 26% increase in net income for fiscal year 2024 compared to 2023. The company saw strong growth in cosmetic ingredients and medical lubricants, but a supply disruption impacted pharmaceutical sales.

    GlobeNewswire Inc.
  • Rare Stock Picks In February 2024 - From 32 Discerning Analysts

    In our monthly Rare Stock Picks series, we're highlighting February 2024 investment picks. Click here for the list of February 2024 Buy recommendations.

    Seeking Alpha
    Featured Companies: AGO AMD AMZN AREC ASLE BHM BOC BORR BXSL CPHC CREX CTRE EPRT FARM FI GILD HII HPQ IRDM MDGL META MKTX MOH PROP RMR SNCY TGTX
  • Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday

    Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split. InMed Pharmaceuticals Inc. (NASDAQ: INM) gained 70.4% to close at $18.78 after the company on Friday announced a $6 million private placement priced at $8.68 per share. Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares surged 65% to close at $38.11 on Monday after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65. PolyPid Ltd. (NASDAQ: PYPD) gained 58.3% to close at $1.71. The company earlier announced it will present Phase 2 D-PLEX₁₀₀ data at the European Society for Coloproctology Scientific Conference next week. Arqit Quantum Inc. (NASDAQ: ARQQ) shares gained 38.1% to close at $7.72. The company will present at the H.C. Wainwright 24th Annual Global Investment Conference later today. PaxMedica, Inc. (NASDAQ: PXMD) rose 36.6% to settle at $4.33 after TardiMed Sciences' Michael Derby on Friday disclosed a 63.4% active stake in the company. Allego N.V. (NYSE: ALLG) jumped 33.5% to close at $5.90. IDEAYA Biosciences, Inc. (NASDAQ: IDYA) jumped 30.7% to close at $12.09. IDEAYA Biosciences disclosed interim Phase 2 clinical results for darovasertib and crizotinib synthetic lethal combination in metastatic uveal melanoma. Clovis Oncology, Inc. (NASDAQ: CLVS) climbed 30.4% to close at $1.50 after the company said Rubraca (Rucaparib) as first-line maintenance treatment improves progression-free survival in women with advanced ovarian cancer across disease risk subgroups. Annovis Bio, Inc. (NYSE: ANVS) gained 29.5% to settle at $19.82 on above-average volume. Kaspien Holdings Inc. (NASDAQ: KSPN) surged 27.7% to close at $2.86. IHS Holding Limited (NYSE: IHS) jumped 24.9% to close at $7.83. IHS Holding, last month, said Q2 EPS results down year-over-year. Gogoro Inc. (NASDAQ: GGR) gained 21.3% to close at $5.25. Gogoro recently launched its battery-swapping system and Smart scooters in the Tel Aviv metropolitan area. ImmunityBio, Inc. (NASDAQ: IBRX) jumped 20.9% to close at $5.61. POINT Biopharma Global Inc. (NASDAQ: PNT) rose 19.8% to close at $10.27 after the company published a poster at ESMO Congress 2022 highlighting updated safety and efficacy data from its Phase 3 SPLASH trial of PNT2002 in metastatic castration-resistant prostate cancer. Rackspace Technology, Inc. (NASDAQ: RXT) gained 18.8% to settle at $6.32. Magic Empire Global Limited (NASDAQ: MEGL) jumped 17.9% to close at $6.00. Regulus Therapeutics Inc. (NASDAQ: RGLS) rose 16.9% to close at $1.94 after the company announced topline safety and PK data from its Phase 1 SAD clinical trial of RGLS8429. The study demonstrated that RGLS8429 has a favorable safety and PK profile. TuanChe Limited (NASDAQ: TC) gained 16.8% to close at $3.20. Asana, Inc. (NYSE: ASAN) climbed 16.4% to close ...

    Benzinga
    Featured Companies: ANVS AREB ARQQ ASAN AUUD BMY CDLX CDRO CVNA EVEX FOA GGR GSHD HYPR IBRX IDAI IDYA IHS IMTX INLX INM IPI LCID LPTX LSAK MEGL NTCT NUWE PYPD RBBN REBN RGLS RXT RYTM SGML SWTX TRDA VTYX W YOSH
Page data last updated 09/07/2025 00:34:29 UTC Dividend yield is calculated using only dividends that have already been paid. Future or declared dividends are not included